Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tanta University | OTHER |
Not provided
Not provided
Not provided
Not provided
study is to evaluate the prevalence of cardiac autonomic neuropathy in children with Type 1 DM and correlation with duration of DM and glycemic control.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Case Group 1-A | Experimental | evaluation of autonomic cardiac neuropathy using 24 hrs rhythm Holter and Cardiac Autonomic Reflex Tests (CARTs) in children and adolescent with type 1 DM for 5 - 10 years |
|
| Case Group 1-B | Experimental | evaluation of autonomic cardiac neuropathy using 24 hrs rhythm Holter and Cardiac Autonomic Reflex Tests (CARTs) in children and adolescent with type 1 DM more than 10 years |
|
| Control Group (Group 2) | Experimental | evaluation of autonomic cardiac neuropathy using 24 hrs rhythm Holter and Cardiac Autonomic Reflex Tests (CARTs) in children and adolescent in healthy children |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Holter | Device | Baseline Electrocardiogram (ECG) Cardiac Autonomic Reflex Tests (CARTs) |
|
| Measure | Description | Time Frame |
|---|---|---|
| evaluate the prevalence of cardiac autonomic neuropathy in children with Type 1 DM and correlation with duration of DM and glycemic control. | up to 24 months |
Not provided
Not provided
Inclusion Criteria:
Age ≤18 years old Both males and females will be included. Patients diagnosed with type 1 DM for a duration ≥ 5 y. Both well controlled and poorly controlled patients will be included.
Exclusion Criteria:
Patients with diabetes other than Type 1 DM. Coexisting medical conditions such as thyroid disorders, celiac disease, epilepsy, or chronic pulmonary or hepatic disease.
Known cardiac conditions, including congenital heart disease, cardiomyopathy, conduction disorders, or previous cardiac surgery.
Acute illness at the time of evaluation or history of diabetic ketoacidosis within the preceding 3 months.
Use of medications affecting heart rate or rhythm, including beta-blockers, theophylline, or levothyroxine
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tanta university | Al Gharbī Bahjūrah | Egypt |
the data will be available upon a reasonable request from the corresponding author after the end of the study for one year
after the end of the study for one year
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015716 | Electrocardiography, Ambulatory |
| ID | Term |
|---|---|
| D004562 | Electrocardiography |
| D006334 | Heart Function Tests |
| D003935 | Diagnostic Techniques, Cardiovascular |
| D019937 | Diagnostic Techniques and Procedures |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D003933 | Diagnosis |
| D004568 | Electrodiagnosis |
| D018670 | Monitoring, Ambulatory |
| D008991 | Monitoring, Physiologic |